CEPHALON, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 138123
 
  
 
C07D HETEROCYCLIC COMPOUNDS 7193
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 15123
 
  
 
C07K PEPTIDES 13123
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1138
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 1085
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 6134
 
  
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 664
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 5162
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 5120

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0056,018 Inhalation Systems, Devices and MethodsAug 29, 17Mar 01, 18[G06F, C07K, A61M]
2018/0021,696 AFFINITY CHROMATOGRAPHY WASH BUFFERJul 25, 17Jan 25, 18[C07K, B01D]
2016/0001,957 Child Resistant Cover for Oral Dosage FormsSep 10, 15Jan 07, 16[A61J, A61K, B65D]
2014/0121,182 PROTEASOME INHIBITORS AND PROCESSES FOR THEIR PREPARATION, PURIFICATION AND USEJun 21, 12May 01, 14[C07F]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9902696 1,4-substituted piperidine derivativesJun 17, 16Feb 27, 18[C07D]
9815894 Use of reslizumab to treat moderate to severe eosinophilic asthmaAug 28, 15Nov 14, 17[A61K, C07K]
9623026 Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitorMay 04, 16Apr 18, 17[A61K, C07D]
9598377 Nanoparticulate and macroparticulate formulationsMar 12, 14Mar 21, 17[A61K, C07D]
9533955 Solid forms of bendamustine hydrochlorideFeb 17, 16Jan 03, 17[A61K, C07D]
9487529 Macrocyclic compounds as ALK, FAK and JAK2 inhibitorsSep 13, 13Nov 08, 16[C07D]
9475766 Substituted aromatic sulfur compounds and methods of their useAug 26, 13Oct 25, 16[A61K, C07D, C07C]
9440984 Pyrrolotriazines as ALK inhibitorsNov 18, 15Sep 13, 16[A61K, C07D]
9339502 Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitorAug 12, 15May 17, 16[A61K, C07D]
9340559 Proteasome inhibitor delanzomib for use in the treatment of lupusMar 02, 12May 17, 16[A61K, C07F]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0027,948 MACROCYCLIC COMPOUNDS AS ALK, FAK AND JAK2 INHIBITORSAbandonedOct 13, 16Feb 02, 17[A61K]
2016/0347,756 PYRROLOTRIAZINES AS ALK INHIBITORSAbandonedAug 09, 16Dec 01, 16[C07D]
2016/0303,116 TREATMENT OF MULTIPLE SCLEROSIS WITH A 1,2,4-TRIAZOLO [1,5A] PYRIDINE DERIVATIVEAbandonedDec 10, 14Oct 20, 16[A61K]
2015/0368,257 Tricyclic Derivatives and Their Pharmaceutical Use and CompositionsAbandonedAug 21, 15Dec 24, 15[C07D]
2015/0011,759 PROCESSES FOR PREPARING (R)-2-METHYLPYRROLIDINE AND (S)-2-METHYLPYRROLIDINE AND TARTRATE SALTS THEREOFAbandonedJul 25, 14Jan 08, 15[C07D, C07C]
2014/0296,212 SUBSTITUTED PHENOXYPROPYLCYCLOAMINE DERIVATIVES AS HISTAMINE-3 (H3) RECEPTOR LIGANDSAbandonedFeb 10, 14Oct 02, 14[C07D, C07C]
2014/0275,102 Solid State Forms of 6-[4-[3-((R)-2-Methylpyrrolidine-1-yl)-propoxy]phenyl] 2H-pyridazine-3-one HydrochlorideAbandonedMar 12, 14Sep 18, 14[C07D]
2014/0206,733 Liquid Formulations Of BendamustineAbandonedMar 21, 14Jul 24, 14[A61K]
2014/0148,490 BENDAMUSTINE PHARMACEUTICAL COMPOSITIONSAbandonedJan 31, 14May 29, 14[A61K]
2014/0142,088 PYRIDAZINONE DERIVATIVESAbandonedNov 18, 13May 22, 14[C07D]
2014/0128,443 Liquid Formulations Of BendamustineAbandonedJan 09, 14May 08, 14[A61K]
2014/0080,881 Liquid Formulations of BendamustineAbandonedNov 20, 13Mar 20, 14[A61K]
8648067 ) receptor ligandsExpiredDec 22, 11Feb 11, 14[A61K, A01N, C07D]
2013/0310,389 SUBSTITUTED SPIROCYCLIC PIPERIDINE DERIVATIVES AS HISTAMINE-3 (H3) RECEPTOR LIGANDSAbandonedJul 24, 13Nov 21, 13[C07D]
2013/0310,571 METHODS FOR THE PREPARATION OF BENDAMUSTINEAbandonedJan 18, 12Nov 21, 13[C07D]
8580308 Modafinil pharmaceutical compositionsExpiredOct 18, 06Nov 12, 13[A61K]
8541590 Proteasome inhibitors and processes for their preparation, purification and useExpiredJun 20, 12Sep 24, 13[A61K, C07D]
8513232 Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligandsExpiredJul 29, 10Aug 20, 13[A61K, C07D, A61P]
2013/0156,825 Modafinil FormulationsAbandonedFeb 21, 13Jun 20, 13[A61K]
2013/0144,068 Methods for the Sterilization of BendamustineAbandonedJan 09, 13Jun 06, 13[A61L]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.